Osteoimmunomodulation in Bone Regeneration

Bone regeneration is governed not only by osteogenic cells but also by the coordinated actions of immune cells, a concept now recognised as osteoimmunomodulation. Following injury or implantation, innate immune cells such as macrophages and dendritic cells infiltrate the defect site and secrete cytokines that either hinder or promote new bone formation. Early pro-inflammatory signals create a clearing and priming phase, while a timely switch to an anti-inflammatory, reparative state supports mesenchymal stem cell recruitment, angiogenesis and matrix deposition. Advances in biomaterial design have focused on harnessing this dynamic immune milieu by tailoring surface chemistry, topography and controlled release of bioactive ions or growth factors. By fine-tuning the balance between inflammatory and regulatory signals, osteoimmunomodulatory strategies aim to accelerate defect healing, improve implant integration and reduce fibrotic encapsulation. The global burden of bone defects in trauma, tumour resection and degenerative disease underscores the need for clinically translatable materials and approaches that align immune regulation with robust tissue repair.

Research from Nature Portfolio

Recent studies have demonstrated that a hierarchically designed zinc-based scaffold, incorporating a Li-alloyed eutectoid structure and nanoscale surface roughness, directs macrophage polarisation toward an anti-inflammatory phenotype. This activation of JAK/STAT pathways in macrophages upregulates Il-4 and Il-10 expression, enhancing osteogenic marker expression, collagen deposition and new bone ingrowth in vivo. Another innovative approach employs a dual-effect coating that co-ordinates immobilised Zn²⁺ ions and BMP-2 peptides via mussel-inspired adhesion chemistry. This synergistic system amplifies M2 macrophage recruitment and upregulates osteoinductive cytokines, ultimately improving bone-implant mechanical fixation and promoting extensive bone tissue integration at the interface.

Osteoimmunomodulation in Bone Regeneration publication trend

The graph below shows the total number of articles in osteoimmunomodulation in bone regeneration across all publications each year (not limited to Nature Index journals).

Technical terms

Osteoimmunomodulation: Strategic regulation of immune responses to favour bone healing.

Macrophage polarisation: The process by which macrophages adopt pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes.

Cytokines: Signalling proteins released by immune cells that direct inflammation and tissue repair.

Biomaterial scaffold: A three-dimensional framework designed to support cell adhesion, growth and differentiation.

Mesenchymal stem cells: Multipotent stromal cells capable of differentiating into osteoblasts and other connective tissue lineages.

References

1. Piezoelectric stimulation enhances bone regeneration in alveolar bone defects through metabolic reprogramming of macrophages. Exploration (2024).
2. Multiscale architecture design of 3D printed biodegradable Zn-based porous scaffolds for immunomodulatory osteogenesis. Nature Communications (2024).
3. Role of dendritic cells in MYD88-mediated immune recognition and osteoinduction initiated by the implantation of biomaterials. International Journal of Oral Science (2023).
4. Ti3C2Tx MXene‐Decorated 3D‐Printed Ceramic Scaffolds for Enhancing Osteogenesis by Spatiotemporally Orchestrating Inflammatory and Bone Repair Responses. Advanced Science (2024).
5. Engineering immunomodulatory and osteoinductive implant surfaces via mussel adhesion-mediated ion coordination and molecular clicking. Nature Communications (2022).